Literature DB >> 18777927

A Monte Carlo study on the effect of seed design on the interseed attenuation in permanent prostate implants.

Hossein Afsharpour1, Michel D'Amours, Benoit Coté, Jean-François Carrier, Frank Verhaegen, Luc Beaulieu.   

Abstract

Standard algorithms for postimplant analysis of transperineal interstitial permanent prostate brachytherapy (TIPPB) are based on AAPM Task Group 43 formalism (TG-43), which makes use of a world entirely made of water. This entails an assignment of the prostate, surrounding organs at risk, as well as all brachytherapy seeds present in a permanent prostate implant to water. Brachytherapy seeds are generally made from high atomic number materials. Because of the simultaneous presence of many brachytherapy seeds in a TIPPB, there is a shielding effect causing an attenuation of energy of the emitted photons generally called the "interseed attenuation" (ISA). This study investigates the impact of seed designs and compositions on the interseed attenuation. For this purpose, six brachytherapy seeds covering a wide variety of seed design and composition were modeled with the GEANT4 Monte Carlo (MC) toolkit. MC has allowed calculation of the contribution of each major component (encapsulation and internal components) of a given seed model to ISA separately. The impact of ISA on real clinical implant configurations was also explored. Two clinical postimplant geometries with different brachytherapy seeds were studied with MC simulations. The change in the clinical parameter D90 was observed. This study shows that Nucletron SelectSeed (similar to the Oncura model 6711), ProstaSeed, and Best Medical model 2335 are the most attenuating designs with 4.8%, 3.9%, and 4.6% of D90 reduction, respectively. The least attenuating seed is a 103Pd seed encapsulated in a polymer shell, the IBt OptiSeed with 1.5%. Finally, based on this systematic study, a new seed design is proposed that is predicted to be the most waterlike brachytherapy seed and thus TG-43 compatible.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777927     DOI: 10.1118/1.2955754

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  7 in total

1.  Reconstruction of brachytherapy seed positions and orientations from cone-beam CT x-ray projections via a novel iterative forward projection matching method.

Authors:  Damodar Pokhrel; Martin J Murphy; Dorin A Todor; Elisabeth Weiss; Jeffrey F Williamson
Journal:  Med Phys       Date:  2011-01       Impact factor: 4.071

2.  AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Authors:  Ravinder Nath; William S Bice; Wayne M Butler; Zhe Chen; Ali S Meigooni; Vrinda Narayana; Mark J Rivard; Yan Yu
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

3.  Experimental computed tomography-guided vena cava puncture in pigs for percutaneous brachytherapy of middle mediastinal lymph node metastases.

Authors:  Min Zhao; Bin Liu; Sheng-Yong Li; Yong-Zheng Wang; Yu-Liang Li; Yancu Hertzanu
Journal:  Chin Med J (Engl)       Date:  2015-04-20       Impact factor: 2.628

4.  An analytical model to determine interseed attenuation effect in low-dose-rate brachytherapy.

Authors:  Habib Safigholi; Dariush Sardari; Somaye Karimi Jashni; Seied Rabi Mahdavi; Ali S Meigooni
Journal:  J Appl Clin Med Phys       Date:  2013-05-06       Impact factor: 2.102

Review 5.  Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM.

Authors:  Christian Kirisits; Mark J Rivard; Dimos Baltas; Facundo Ballester; Marisol De Brabandere; Rob van der Laarse; Yury Niatsetski; Panagiotis Papagiannis; Taran Paulsen Hellebust; Jose Perez-Calatayud; Kari Tanderup; Jack L M Venselaar; Frank-André Siebert
Journal:  Radiother Oncol       Date:  2013-11-30       Impact factor: 6.280

6.  Monte Carlo study of a new I-125 brachytherapy prototype seed with a ceramic radionuclide carrier and radiographic marker.

Authors:  Lucas Paixão; Alessandro Facure; Ana Maria M Santos; Adriano Márcio dos Santos; Suely Epsztein Grynberg
Journal:  J Appl Clin Med Phys       Date:  2012-05-10       Impact factor: 2.102

7.  The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy.

Authors:  Anna Sophie Duque; Stefanie Corradini; Florian Kamp; Max Seidensticker; Florian Streitparth; Christopher Kurz; Franziska Walter; Katia Parodi; Frank Verhaegen; Jens Ricke; Claus Belka; Gabriel Paiva Fonseca; Guillaume Landry
Journal:  Radiat Oncol       Date:  2020-03-09       Impact factor: 3.481

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.